Palladiem’s Medtronic MDT Stock Holding History

Palladiem’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$83.6K	Buy	1,068 +2	+0.2%	+$161	0.08%	93
2026 Q1	$93.7K	Buy	1,066 +2	+0.2%	+$192	0.09%	74
2025 Q4	$103K	Buy	+1,064	New	+$103K	0.1%	76
2022 Q2	–	Sell	-1,900	Closed	-$211K	–	56
2022 Q1	$211K	Buy	+1,900	New	+$201K	0.19%	52
2021 Q4	–	Sell	-1,900	Closed	-$238K	–	66
2021 Q3	$238K	Hold	1,900	–	–	0.19%	46
2021 Q2	$236K	Hold	1,900	–	–	0.19%	55
2021 Q1	$224K	Hold	1,900	–	–	0.2%	51
2020 Q4	$223K	Buy	+1,900	New	+$209K	0.21%	53
2015 Q3	$64K	Hold	953	–	–	0.1%	45
2015 Q2	$71K	Hold	953	–	–	0.06%	49
2015 Q1	$74K	Sell	953 -47	-5%	-$3.56K	0.06%	57
2014 Q4	$72K	Buy	+1,000	New	+$69.5K	0.06%	60

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Palladiem's MDT Position: Q2 2026 in Review

Palladiem increased its Medtronic (MDT) stake by 0.19% in Q2 2026, buying an estimated $161 and bringing the position to 1,068 shares worth $83.6K. The position accounts for 0.08% of the portfolio, ranked #93.

Palladiem first reported a position in MDT in Q4 2014 and has held it in 12 quarters since. The position peaked at $238K in Q3 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Palladiem held 1,068 shares of Medtronic worth $83.6K as of Q2 2026.
Palladiem bought 2 Medtronic shares in Q2 2026, an estimated $161.
Medtronic made up 0.08% of Palladiem's portfolio in Q2 2026, its #93 holding.
Palladiem first reported a position in Medtronic in Q4 2014 and has held it in 12 quarters since.
Palladiem's Medtronic position peaked at $238K in Q3 2021.
2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Palladiem's 13F filing for Q2 2026, filed 13 Aug 2026.